← Leaderboards
Daniel Russakoff
Voxeleron, Llc
$1,838,470
Attributed
$1,838,470
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $988.6K · FY2017–22$1M$750K$500K$250K$0
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$1,838,470 · 2
By mechanism
R44$1,615,479 · 1
R43$222,991 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Liquid Substance”
- Hanjoon Ryu$28,519,898
- Scott Fry$21,470,000
- Maria C Carrillo · Indiana University Indianapolis$19,445,642
- Claudia L Satizabal · Boston University Medical Campus$10,721,425
- Leonard Freedman · Leidos Biomedical Research, Inc.$10,469,484
- Jeanette Coffin · Midwest Research Institute$10,204,323
Research focus
Liquid SubstanceOphthalmologyGlaucomaInterestModalityOcular PathologyDevicesDisease ManagementComputer SoftwareImage AnalysisLongitudinal AnalysisManufacturer NameAlzheimer&AposNeurodegenerative DisordersAmericanData SetAffectDiabetic RetinopathyClinical ResearchCloud BasedAngiographyImageDatabasesOptical Coherence Tomography
Grant awards (3)
Retinal image analysis software for neurodegenerative disease research$626,846
R44 · FY2022 · TR · contact PI
Retinal image analysis software for neurodegenerative disease research$988,633
R44 · FY2021 · TR · contact PI
Retinal image analysis software for neurodegenerative disease research$222,991
R43 · FY2017 · TR · contact PI